Home » Newsletters » BioWorld Science

BioWorld Science

June 29, 2021

View Archived Issues

OPS-2071 shows potent in vitro and in vivo activity against Clostridioides difficile

New Raf kinase C inhibitors identified at Medshine Discovery

Cadila Healthcare discovers NLRP3 inflammasome inhibitors

Kallyope describes new SSTR5 antagonists

New PRMT5 inhibitors discovered at Lupin

First-in-human study finds CEB-01 implant safe in patients with retroperitoneal soft tissue sarcoma

TAT therapy with FPI-1792 plus checkpoint inhibitors eradicates colon cancer tumors in vivo

Second ANAVEX2-73 trial confirms SIGMAR1 mRNA expression as predictive biomarker of response

Topline phase I data presented for DARE-HRT1 for hormonal therapy after menopause

Genetic study unveils loss-of-function variants in BCAS3 causing a neurodevelopmental disorder

RNA helicase DDX3X identified as an attractive target for host-directed therapy against SARS-CoV-2

Ideaya provides clinical updates for IDE-397 phase I study and darovasertib combination trial

First patient dosed in phase I/II study of ANV-419 in solid tumors

Umbilical cord-derived mesenchymal stem cells show clinical efficacy in patients with COVID-19

FDA clears IND application for ORIC-533

Interim data from phase II CORIST study of SCO-101 in metastatic colorectal cancer

LDL receptor overexpression affects tauopathy in Alzheimer's model

Venatorx initiates phase I trial of VNRX-9945 for chronic hepatitis B

Human placenta-derived exosomes for the treatment of ischemia

Q-State reports preclinical proof-of-concept data for QSB-490 in spastic paraplegia type 49

First-in-human data for SCO-267 in healthy adults and subjects with glucose intolerance

SAB Biotherapeutics initiates phase IIa trial of SAB-176 for influenza

DiaMedica reports interim phase II data on DM-199 in chronic kidney disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...